Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bibekanand Mallick

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
DNA Repair|August 22, 2024
miR-185-5p rewires cisplatin resistance by restoring miR-203a-3p expression via downregulation of SOX9Priyajit Biswal, Bibekanand Mallick
Journal of Molecular Recognition : JMR|September 18, 2023
LncRNA-associated competing endogenous RNA network analysis uncovered key lncRNAs involved in temozolomide resistance and tumor recurrence of glioblastomaRojalin Nayak, Bibekanand Mallick
Journal of Molecular Recognition : JMR|September 13, 2018
Modulation of specific cell cycle phases in human embryonic stem cells by lncRNA RNA decoysMousumi Sahu, Bibekanand Mallick
Archives of Biochemistry and Biophysics|September 12, 2024
Unlocking the potential of signature-based drug repurposing for anticancer drug discoverySruti Biswal, Bibekanand Mallick
Cancer Genetics|August 30, 2024
BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screeningRojalin Nayak, Bibekanand Mallick
Journal of Molecular Recognition : JMR|January 3, 2022
Predicting sequence and structural features of effective piRNA target binding sitesGarima Singh, Bibekanand Mallick
RNA Biology|June 11, 2011
A complex crosstalk between polymorphic microRNA target sites and AD prognosisBibekanand Mallick, Zhumur Ghosh
Experimental Cell Research|April 23, 2017
miR-429 inhibits metastasis by targeting KIAA0101 in Soft Tissue SarcomaDevyani Samantarrai, Bibekanand Mallick
Molecular Biology Reports|October 30, 2024
miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targetingPooja Gupta, Bibekanand Mallick
Life Sciences|July 20, 2023
FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinomaTrisha Chattopadhyay, Bibekanand Mallick
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
DNA Repair|August 22, 2024
miR-185-5p rewires cisplatin resistance by restoring miR-203a-3p expression via downregulation of SOX9Priyajit Biswal, Bibekanand Mallick
Journal of Molecular Recognition : JMR|September 18, 2023
LncRNA-associated competing endogenous RNA network analysis uncovered key lncRNAs involved in temozolomide resistance and tumor recurrence of glioblastomaRojalin Nayak, Bibekanand Mallick
Journal of Molecular Recognition : JMR|September 13, 2018
Modulation of specific cell cycle phases in human embryonic stem cells by lncRNA RNA decoysMousumi Sahu, Bibekanand Mallick
Archives of Biochemistry and Biophysics|September 12, 2024
Unlocking the potential of signature-based drug repurposing for anticancer drug discoverySruti Biswal, Bibekanand Mallick
Cancer Genetics|August 30, 2024
BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screeningRojalin Nayak, Bibekanand Mallick
Journal of Molecular Recognition : JMR|January 3, 2022
Predicting sequence and structural features of effective piRNA target binding sitesGarima Singh, Bibekanand Mallick
RNA Biology|June 11, 2011
A complex crosstalk between polymorphic microRNA target sites and AD prognosisBibekanand Mallick, Zhumur Ghosh
Experimental Cell Research|April 23, 2017
miR-429 inhibits metastasis by targeting KIAA0101 in Soft Tissue SarcomaDevyani Samantarrai, Bibekanand Mallick
Molecular Biology Reports|October 30, 2024
miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targetingPooja Gupta, Bibekanand Mallick
Life Sciences|July 20, 2023
FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinomaTrisha Chattopadhyay, Bibekanand Mallick
Pageof 8